HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction

Author： Riahi S. Hagstrup Christensen J. Toft E. Aarup Skou H. Berg Schmidt E.

ISSN： 1043-6618

Source： Pharmacological Research, Vol.45, Iss.6, 2002-06, pp. : 479-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike?

By Maroo Bijesh P. Lavie Carl J. Milani Richard V.

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 649-664

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 1, 2009-03 ,pp. : 1-26

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to Increase HMG-CoA Reductase Inhibitor Use After Acute Myocardial Infarction

By Joseph B. Muhlestein

Drugs & Aging, Vol. 21, Iss. 9, 2004-01 ,pp. : 583-595

Adis International

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in the Prevention of Stroke

By van Mil A.H.M.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite